{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:08:29Z","timestamp":1789945709320,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Kronos Science Laboratory"},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01MH57899"],"award-info":[{"award-number":["R01MH57899"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01AG031581"],"award-info":[{"award-number":["R01AG031581"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P30AG19610"],"award-info":[{"award-number":["P30AG19610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Arizona Alzheimer's Disease Center","award":["AG023193"],"award-info":[{"award-number":["AG023193"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01 NS059873"],"award-info":[{"award-number":["R01 NS059873"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State of Arizona"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.neuroimage.2010.09.066","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T05:29:00Z","timestamp":1285997340000},"page":"1896-1902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOE\u03b54 carriers"],"prefix":"10.1016","volume":"54","author":[{"given":"Winnie S.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Sidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Corneveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April N.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bessie","family":"Meechoovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Pruzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Fleisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.S.","family":"Langbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Huentelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Dunckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroimage.2010.09.066_bb0005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.159.5.738","article-title":"Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies","volume":"159","author":"Alexander","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0270(94)90168-6","article-title":"Single-day apolipoprotein E genotyping","volume":"53","author":"Crook","year":"1994","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0025","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0030","first-page":"6","article-title":"Examination of the current top candidate genes for AD in a genome-wide association study","volume":"6","author":"Feulner","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0050","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.biopsych.2008.11.014","article-title":"The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis","volume":"65","author":"Ikram","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuroimage.2008.12.072","article-title":"Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)","volume":"45","author":"Langbaum","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2007.3","article-title":"Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease","volume":"65","author":"Li","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0075","first-page":"19","article-title":"GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han","volume":"19","author":"Lin","year":"2009","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/cercor\/6.1.50","article-title":"Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes","volume":"6","author":"Magistretti","year":"1996","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0085","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","article-title":"Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation","volume":"17","author":"Mark","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0090","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng.238","article-title":"Integrated detection and population-genetic analysis of SNPs and copy number variation","volume":"40","author":"McCarroll","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ejhg.2008.181","article-title":"GAB2 is not associated with late-onset Alzheimer's disease in Japanese","volume":"17","author":"Miyashita","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3233\/JAD-2009-1005","article-title":"Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease","volume":"16","author":"Nacmias","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jhg.2009.95","article-title":"Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse","volume":"54","author":"Nakaoka","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v67n0418","article-title":"Genetics, transcriptomics, and proteomics of Alzheimer's disease","volume":"67","author":"Papassotiropoulos","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0120","first-page":"201","article-title":"Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET","volume":"37","author":"Piert","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12603-009-0061-6","article-title":"GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers","volume":"13","author":"Ramirez-Lorca","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0135","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0140","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuroimage.2009.07.025","article-title":"Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging","volume":"49","author":"Reiman","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archneurol.2008.552","article-title":"GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results","volume":"66","author":"Schjeide","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.462184","article-title":"Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat","volume":"205","author":"Schwartz","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0165","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1002\/humu.20909","article-title":"Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia","volume":"30","author":"Sleegers","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wad.0000191420.61260.a8","article-title":"The role of biomarkers in clinical trials for Alzheimer disease","volume":"20","author":"Thal","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuroimage.2010.09.066_bb0180","series-title":"Co-Planar Stereotactic Atlas of the Human Brain","author":"Tournoux","year":"1988"}],"container-title":["NeuroImage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811910012681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053811910012681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:45:28Z","timestamp":1760953528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811910012681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1053811910012681"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.066","relation":{},"ISSN":["1053-8119"],"issn-type":[{"value":"1053-8119","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOE\u03b54 carriers","name":"articletitle","label":"Article Title"},{"value":"NeuroImage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroimage.2010.09.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}